Sijmen de Vries
Algemeen Directeur bij PHARMING GROUP N.V.
Vermogen: 8 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Sijmen de Vries
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
| Public Company | Pharmaceuticals: Major | 23 | |
BioConnection BV
 BioConnection BV BiotechnologyHealth Technology BioConnection BV manufactures and develops injectable pharmaceutical products. Its services include fill & finish, freeze drying, clinical trial material services, project management and consultancy services. The company was founded in 2005 and is headquartered in Oss, the Netherlands.
4
| Holding Company | Biotechnology | 4 |
Midatech Ltd.
 Midatech Ltd. BiotechnologyHealth Technology Midatech Ltd. engages in research and experimental development on biotechnology services. The company is headquartered in Abingdon, the United Kingdom.
1
| Subsidiary | Biotechnology | 1 |
Pharming Intellectual Property BV
 Pharming Intellectual Property BV Trucks/Construction/Farm MachineryProducer Manufacturing Part of Pharming Group NV, Pharming Intellectual Property BV manufactures milking equipment. The company is based in Leiden, Netherlands. The CEO of the Dutch company is Sijmen de Vries.
1
| Subsidiary | Trucks/Construction/Farm Machinery | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sijmen de Vries via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Utrecht | College/University | Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Midatech Pharma (Wales) Ltd.
 Midatech Pharma (Wales) Ltd. Pharmaceuticals: MajorHealth Technology Midatech Pharma (Wales) Ltd. develops advanced life science and therapeutic products. The company was founded on October 10, 2003 and is headquartered in Cardiff, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman Sales & Marketing | |
| Bayes Business School | College/University | Masters Business Admin Masters Business Admin | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ERGOMED | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Amsterdam | College/University | Doctorate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Erasmus University Rotterdam | College/University | Doctorate Degree Graduate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
SpaceCode Holding SA
 SpaceCode Holding SA Investment ManagersFinance SpaceCode Holding SA operates as a holding company whose subsidiaries provide asset tracking system solutions and manufactures diamonds and jewellery. It offers implementation services, prospective customers, and technical support. The company was founded by Pavlo Protopapa and Craig Richard Cook in 2005 and is headquartered in Geneva, Switzerland. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Vrije Universiteit Amsterdam | College/University | Graduate Degree Graduate Degree | |
| MORPHOSYS AG | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree | |
| London Business School | College/University | Graduate Degree Masters Business Admin | |
Centre for Human Drug Research
 Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | Biotechnology | Director/Board Member Director/Board Member | |
ViroClinics Biosciences BV
 ViroClinics Biosciences BV Pharmaceuticals: MajorHealth Technology ViroClinics Biosciences BV engages in the provision of diagnostic and clinical trial solutions. It offers research and development, preclinical, clinical trial operation, diagnostic testing, virus discovery, and quality assurance services. The company was founded by Albert Osterhaus in 2001 and is headquartered in Rotterdam, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Mellon Medical BV
 Mellon Medical BV Medical SpecialtiesHealth Technology Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Chairman | |
Rodger BV
 Rodger BV Medical DistributorsDistribution Services Rodger BV is a Dutch company that wholesales medical and dental instruments. The private company is based in Denekamp, Netherlands. | Medical Distributors | Director/Board Member | |
Global Healthcare Exchange LLC
 Global Healthcare Exchange LLC Packaged SoftwareTechnology Services Global Healthcare Exchange LLC engages in the provision of supply chain automation services for the healthcare sector. It offers E-commerce; Contracting; AP Automation; Data Management; Business Intelligence; and Compliance and Credentialing solutions. The company was founded in 2000 and is headquartered in Louisville, CO. | Packaged Software | Founder | |
Tens Health BV
 Tens Health BV Miscellaneous Commercial ServicesCommercial Services Tens Health BV provides health consulting services. The private company is based in Ravenstein, Netherlands. | Miscellaneous Commercial Services | Director/Board Member | |
Pelvitec BV
 Pelvitec BV Medical DistributorsDistribution Services Pelvitec BV is a Dutch company that wholesales medical and dental equipment. The private company is based in Delft, Netherlands. | Medical Distributors | Director/Board Member | |
Vaccinatiezorg BV
 Vaccinatiezorg BV Medical/Nursing ServicesHealth Services Vaccinatiezorg BV provides infection prevention and related medical services. The private company is based in Ravenstein, Netherlands. The CEO of the Dutch company is Jan Hendrik Egberts. | Medical/Nursing Services | Chief Executive Officer | |
| PHOTOCURE ASA | Medical Specialties | Chairman | |
Sigmascreening BV
 Sigmascreening BV Wholesale DistributorsDistribution Services Sigmascreening BV develops new diagnostic products for breast cancer screening. It offers its products to improve the digital mammography in the screening. The company was founded by Kees Grimbergen, Ard den Heeten and Emile Konps in July 2010 and is headquartered in Amsterdam, the Netherlands. | Wholesale Distributors | Director/Board Member | |
Nlc Investments Ltd.
 Nlc Investments Ltd. Financial ConglomeratesFinance Nlc Investments Ltd. provides investment services. | Financial Conglomerates | Director/Board Member | |
Veritas Investments
 Veritas Investments Financial ConglomeratesFinance Veritas Investments provides investment services. The private company is based in The Hague, Netherlands. The CEO of the Dutch company is Jan Hendrik Egberts. | Financial Conglomerates | Chief Executive Officer | |
| EMMIS CORPORATION | Broadcasting | Human Resources Officer | |
NYSE Euronext, Inc.
 NYSE Euronext, Inc. Financial ConglomeratesFinance NYSE Euronext operates financial markets and provides trading solutions. It offers an array of products and services in cash equities, futures, options, swaps, exchange-traded products, bonds, clearing operations, market data, commercial technology solutions and carbon trading, all designed to meet the evolving needs of investors, issuers, financial institutions and market participants. The company was founded by Jean-François Théodore in 2007 and is headquartered in New York, NY. | Financial Conglomerates | Corporate Officer/Principal | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of South Africa | College/University | Undergraduate Degree | |
| University of the Witwatersrand | College/University | Undergraduate Degree | |
Socure, Inc.
 Socure, Inc. Packaged SoftwareTechnology Services Socure, Inc. provides online identity verification application. It develops ways to mitigate identity fraud risks for businesses. The firm's Social Biometrics technology applies artificial intelligence and machine-learning techniques with online/offline data intelligence from email, phone, address, IP, social media and the broader Internet to authenticate identities in real-time. The company was founded by Johnny Ayers and Sunil Madhu in 2012 and is headquartered in New York, NY. | Packaged Software | Director/Board Member |
Statistieken
Internationaal
| Nederland | 19 |
| Verenigde Staten | 13 |
| Verenigd Koninkrijk | 9 |
| Zwitserland | 5 |
| Noorwegen | 3 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 6 |
| Distribution Services | 5 |
Operationeel
| Director/Board Member | 240 |
| Corporate Officer/Principal | 119 |
| Chairman | 61 |
| Independent Dir/Board Member | 61 |
| Chief Executive Officer | 49 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Stephen Parker | 34 |
| Jan Hendrik Egberts | 33 |
| James Phillips | 24 |
| Leonard Kruimer | 22 |
| Deborah Jorn | 20 |
| Huai Zheng Peng | 19 |
| Jeffrey Brown | 19 |
| Mark Pykett | 19 |
| John Barrie Ward | 18 |
| Jabine T. M. van der Meijs | 18 |
| Karl Keegan | 18 |
| Steven Baert | 16 |
| Simon Turton | 16 |
| Richard Peters | 16 |
- Beurs
- Insiders
- Sijmen de Vries
- Bedrijfsconnecties
